L34F (p.Leu34Phe) variant of AGT (Angiotensinogen)

L34F (p.Leu34Phe) in AGT (Angiotensinogen) is a missense change. Clinical records from EBI and UniProt describe it as benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.56 / 1. The record also includes population frequency data, published literature, and structural context.

L34F (p.Leu34Phe) variant details